Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis

Digestive and Liver Disease

Volumn 48, Issue 12, 2016, Pages 1410-1417

  Jaruvongvanich, Veeravich ^a,b   Wirunsawanya, Kamonkiat ^a   Sanguankeo, Anawin ^c,d   Upala, Sikarin ^c,d  

^a UNIVERSITY OF HAWAII   (United States)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c Bassett Medical Center and Columbia University College of Physicians and Surgeons ^*  (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Coronary artery disease; Coronary calcification; Coronary calcium; Meta analysis; Nonalcoholic fatty liver disease

Indexed keywords

CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; HUMAN; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; BLOOD VESSEL CALCIFICATION; COMPLICATION; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; META ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

CORONARY VESSELS; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 85006379690     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.09.002     Document Type: Review

References (54)

1. [1] Younossi, Z.M., Koenig, A.B., Abdelatif, D., et al. Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes. Hepatology 64:1 (2016), 73–84, 10.1002/hep.28431.
2. [2] Angulo, P., Nonalcoholic fatty liver disease. The New England Journal of Medicine 346 (2002), 1221–1231.
3. [3] Rinella, M.E., Nonalcoholic fatty liver disease: a systematic review. JAMA 313 (2015), 2263–2273.
4. [4] Clark, J.M., The epidemiology of nonalcoholic fatty liver disease in adults. Journal of Clinical Gastroenterology 40:Suppl. 1 (2006), S5–S10.
5. [5] Huang, R.C., Beilin, L.J., Ayonrinde, O., et al. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology 58 (2013), 1306–1314.
6. [6] Oni, E.T., Agatston, A.S., Blaha, M.J., et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?. Atherosclerosis 230 (2013), 258–267.
7. [7] Long, M.T., Wang, N., Larson, M.G., et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arteriosclerosis, Thrombosis, and Vascular Biology 35 (2015), 1284–1291.
8. [8] Pais, R., Giral, P., Khan, J.F., et al. Fatty liver is an independent predictor of early carotid atherosclerosis. Journal of Hepatology 65 (2016), 95–102.
9. [9] Lu, H., Liu, H., Hu, F., et al. Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis. International Journal of Endocrinology, 2013, 2013 Article ID 124958.
10. [10] Pletcher, M.J., Tice, J.A., Pignone, M., et al. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Archives of Internal Medicine 164 (2004), 1285–1292.
11. [11] Detrano, R., Guerci, A.D., Carr, J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. The New England Journal of Medicine 358 (2008), 1336–1345.
12. [12] Knapper, J.T., Khosa, F., Blaha, M.J., et al. Coronary calcium scoring for long-term mortality prediction in patients with and without a family history of coronary disease. Heart 102 (2016), 204–208.
13. [13] Nakanishi, R., Li, D., Blaha, M.J., et al. The relationship between coronary artery calcium score and the long-term mortality among patients with minimal or absent coronary artery risk factors. International Journal of Cardiology 185 (2015), 275–281.
14. [14] Hecht, H.S., Coronary artery calcium scanning: past, present, and future. JACC Cardiovascular Imaging 8 (2015), 579–596.
15. [15] Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
16. [16] Agatston, A.S., Janowitz, W.R., Hildner, F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology 15 (1990), 827–832.
17. [17] Stang, A., Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 25 (2010), 603–605.
18. [18] Higgins, J.P., Thompson, S.G., Deeks, J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
19. [19] Sterne, J.A., Egger, M., Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. Journal of Clinical Epidemiology 54 (2001), 1046–1055.
20. [20] Chen, C.H., Nien, C.K., Yang, C.C., et al. Association between nonalcoholic fatty liver disease and coronary artery calcification. Digestive Diseases and Sciences 55 (2010), 1752–1760.
21. [21] Jung, D.H., Lee, Y.J., Ahn, H.Y., et al. Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification. Clinical Chemistry and Laboratory Medicine 48 (2010), 1829–1834.
22. [22] Kim, D., Choi, S.Y., Park, E.H., et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56 (2012), 605–613.
23. [23] Sung, K.C., Wild, S.H., Kwag, H.J., et al. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care 35 (2012), 2359–2364.
24. [24] Chhabra, R., O'Keefe, J.H., Patil, H., et al. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. Mayo Clinic Proceedings 88 (2013), 1259–1265.
25. [25] Juarez-Rojas, J.G., Medina-Urrutia, A.X., Jorge-Galarza, E., et al. Fatty liver increases the association of metabolic syndrome with diabetes and atherosclerosis. Diabetes Care 36 (2013), 1726–1728.
26. [26] Khashper, A., Gaspar, T., Azencot, M., et al. Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics. International Journal of Cardiology 162 (2013), 184–188.
27. [27] Sung, K.C., Lim, Y.H., Park, S., et al. Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort. Cardiovascular Diabetology, 12, 2013, 162.
28. [28] Posadas-Romero, C., Jorge-Galarza, E., Posadas-Sanchez, R., et al. Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis. European Journal of Endocrinology/European Federation of Endocrine Societies 171 (2014), 319–325.
29. [29] VanWagner, L.B., Ning, H., Lewis, C.E., et al. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. Atherosclerosis 235 (2014), 599–605.
30. [30] Al Rifai, M., Silverman, M.G., Nasir, K., et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 239 (2015), 629–633.
31. [31] Kang, M.K., Kang, B.H., Kim, J.H., Nonalcoholic fatty liver disease is associated with the presence and morphology of subclinical coronary atherosclerosis. Yonsei Medical Journal 56 (2015), 1288–1295.
32. [32] Kim, M.K., Ahn, C.W., Nam, J.S., et al. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. Menopause 22 (2015), 1323–1327.
33. [33] Lee, M.K., Park, H.J., Jeon, W.S., et al. Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. Cardiovascular Diabetology, 14, 2015, 88.
34. [34] Mellinger, J.L., Pencina, K.M., Massaro, J.M., et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. Journal of Hepatology 63 (2015), 470–476.
35. [35] Osawa, K., Miyoshi, T., Yamauchi, K., et al. Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT. PLoS One, 10, 2015, e0131138.
36. [36] Targher, G., Byrne, C.D., Lonardo, A., et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. Journal of Hepatology 65:3 (2016), 589–600, 10.1016/j.jhep.2016.05.013.
37. [37] Musso, G., Gambino, R., Cassader, M., et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine 43 (2011), 617–649.
38. [38] Sookoian, S., Pirola, C.J., Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. Journal of Hepatology 49 (2008), 600–607.
39. [39] Ampuero, J., Gallego-Duran, R., Romero-Gomez, M., Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva 107 (2015), 10–16.
40. [40] Fan, Y., Wei, F., Zhou, Y., et al. Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: a meta-analysis. Hepatology Research 46 (2016), E165–E173.
41. [41] Terry, J.G., Carr, J.J., Tang, R., et al. Coronary artery calcium outperforms carotid artery intima-media thickness as a noninvasive index of prevalent coronary artery stenosis. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2005), 1723–1728.
42. [42] Liu, J., Musani, S.K., Bidulescu, A., et al. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 224 (2012), 521–525.
43. [43] Lee, Y.H., Wu, Y.J., Liu, C.C., et al. The severity of fatty liver disease relating to metabolic abnormalities independently predicts coronary calcification. Radiology Research and Practice, 2011, 2011, 586785.
44. [44] Polimeni, L., Del Ben, M., Baratta, F., et al. Oxidative stress: new insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World Journal of Hepatology 7 (2015), 1325–1336.
45. [45] Liu, H., Lu, H.Y., Nonalcoholic fatty liver disease and cardiovascular disease. World Journal of Gastroenterology 20 (2014), 8407–8415.
46. [46] Ginsberg, H.N., Insulin resistance and cardiovascular disease. The Journal of Clinical Investigation 106 (2000), 453–458.
47. [47] Sookoian, S., Castano, G.O., Burgueno, A.L., et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 209 (2010), 585–591.
48. [48] Lonardo, A., Sookoian, S., Pirola, C.J., et al. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism: Clinical and Experimental 65 (2016), 1136–1150.
49. [49] Petta, S., Valenti, L., Marchesini, G., et al. PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One, 8, 2013, e74089.
50. [50] Pirola, C.J., Sookoian, S., The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis. Hepatology 62 (2015), 1742–1756.
51. [51] Zhao, D., Liu, J., Xie, W., et al. Cardiovascular risk assessment: a global perspective. Nature Reviews Cardiology 12 (2015), 301–311.
52. [52] Lonardo, A., Ballestri, S., Targher, G., et al. Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 9 (2015), 629–650.
53. [53] Adams, L.A., Anstee, Q.M., A fatty liver leads to a broken heart?. Journal of Hepatology 65 (2016), 14–16.
54. [54] Lee, S.S., Park, S.H., Radiologic evaluation of nonalcoholic fatty liver disease. World Journal of Gastroenterology 20 (2014), 7392–7402.